Back to Agenda
Session 6: Driving the adoption of PROs in Clinical Practice
Session Chair(s)
Tom Willgoss, PhD, MSc
Head of Late Stage Portfolio and Com., Patient Centered Outcomes Research
Roche Products Ltd, United Kingdom
In this session, we will take a look at what the future should and could look like for PROs: How do we ensure higher integration of PROs in routine clinical practice and that these measures become routine and part of the standard of care? How can PRO data be integrated seamlessly into the clinical workflow? How do we contextualise data collection to patients and ensure they understand the value and interact with the data (the right questions, for the right patient, at the right time)?
Speaker(s)
The status of Health Outcomes and Transparency across Europe – why we should measure PROs and the Value this creates for all Stakeholders in the Healthcare Ecosystem
Christina Akerman, DrMed, MD
Affiliate Faculty At the Dell Medical School At the University of Texas At Austi, Sweden
Affiliate Faculty at the Dell Medical School at the University of Texas at Austi
Levelling PROs with Clinical Outcomes – integrating patient-generated data with routine clinical data and leveraging at the point of care
Matthias Rose
Charité – Universitätsmedizin, Germany
Chair of the Department of Psychosomatic Medicine
PROs in clinical practice from the patient perspective – what drives patient adoption and what value do they provide to patients?
Avril Daly
Retina International, Ireland
CEO
PROs in clinical practice from the patient perspective – what drives patient adoption and what value do they provide to patients?
Salvatore Leone
European Federation of Crohn’s and Ulcerative Colitis Federations, Belgium
Chairman
Have an account?